OS indicates overall survival; NA, not applicable; JALSG, Japanese Acute Leukemia Study Group; Ph+, Philadelphia positive; GMALL, German Multicenter ALL; GRAAPH, Group for Research in Adult Acute Lymphoblastic Leukemia; PETHEMA, Programa para el Estudio de la Terapéutica en Hemopatía Maligna; GIMEMA, Gruppo Italiano Malatti EMatologiche dell'Adulto; LAL, Spanish abbreviation for ALL; NCRI, National Cancer Research Institute; UKALL, United Kingdom ALL Group.

Adapted from a table supplied by Dr A.K. Fielding.